Table 5 Estimated numbers of RPE65-RD cases per center in the country (min–max).

From: Current management of inherited retinal degenerations in Portugal (IRD-PT survey)

 

Biallelic mutations

Patients eligible for treatment

Percentage of patients treated with neparvovec*

Min

1

1

0%

Max

20

10

75%

  1. *considering treatment in at least one eye.